دورية أكاديمية
Obesity and Fibrosis: Setting the Stage for Breast Cancer.
| العنوان: | Obesity and Fibrosis: Setting the Stage for Breast Cancer. |
|---|---|
| المؤلفون: | Kuziel G; Cancer Biology Graduate Program, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI 53705, USA., Moore BN; Department of Comparative Biosciences, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA., Arendt LM; Cancer Biology Graduate Program, University of Wisconsin-Madison, 1111 Highland Ave, Madison, WI 53705, USA.; Department of Comparative Biosciences, University of Wisconsin-Madison, 2015 Linden Drive, Madison, WI 53706, USA. |
| المصدر: | Cancers [Cancers (Basel)] 2023 May 26; Vol. 15 (11). Date of Electronic Publication: 2023 May 26. |
| نوع المنشور: | Journal Article; Review |
| اللغة: | English |
| بيانات الدورية: | Publisher: MDPI Country of Publication: Switzerland NLM ID: 101526829 Publication Model: Electronic Cited Medium: Print ISSN: 2072-6694 (Print) Linking ISSN: 20726694 NLM ISO Abbreviation: Cancers (Basel) Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Original Publication: Basel, Switzerland : MDPI |
| مستخلص: | Obesity is a rising health concern and is linked to a worsened breast cancer prognosis. Tumor desmoplasia, which is characterized by elevated numbers of cancer-associated fibroblasts and the deposition of fibrillar collagens within the stroma, may contribute to the aggressive clinical behavior of breast cancer in obesity. A major component of the breast is adipose tissue, and fibrotic changes in adipose tissue due to obesity may contribute to breast cancer development and the biology of the resulting tumors. Adipose tissue fibrosis is a consequence of obesity that has multiple sources. Adipocytes and adipose-derived stromal cells secrete extracellular matrix composed of collagen family members and matricellular proteins that are altered by obesity. Adipose tissue also becomes a site of chronic, macrophage-driven inflammation. Macrophages exist as a diverse population within obese adipose tissue and mediate the development of fibrosis through the secretion of growth factors and matricellular proteins and interactions with other stromal cells. While weight loss is recommended to resolve obesity, the long-term effects of weight loss on adipose tissue fibrosis and inflammation within breast tissue are less clear. Increased fibrosis within breast tissue may increase the risk for tumor development as well as promote characteristics associated with tumor aggressiveness. |
| References: | Cell. 2009 Nov 25;139(5):891-906. (PMID: 19931152) Cytokine Growth Factor Rev. 2004 Aug;15(4):255-73. (PMID: 15207816) Elife. 2022 Jul 01;11:. (PMID: 35775614) Diabetes. 2010 Jul;59(7):1648-56. (PMID: 20357360) Breast Cancer Res. 2016 Nov 3;18(1):108. (PMID: 27809866) Front Nutr. 2021 Feb 17;8:625331. (PMID: 33681276) Eur J Cancer. 2013 Nov;49(17):3588-97. (PMID: 23953055) Am J Physiol Endocrinol Metab. 2019 Mar 1;316(3):E504-E509. (PMID: 30620639) Diabetes. 2017 Feb;66(2):392-406. (PMID: 28108608) Biochem Biophys Res Commun. 1999 Apr 2;257(1):79-83. (PMID: 10092513) Kidney Int. 2013 Jul;84(1):78-89. (PMID: 23486523) Breast Cancer Res Treat. 2013 Jun;139(2):371-9. (PMID: 23709090) Nat Rev Endocrinol. 2014 Dec;10(12):737-48. (PMID: 25311396) J Biomed Opt. 2020 Jan;25(1):1-14. (PMID: 31983145) Proc Nutr Soc. 2001 Aug;60(3):349-56. (PMID: 11681809) Front Oncol. 2014 Jul 08;4:175. (PMID: 25072025) Stem Cells Int. 2017;2017:9216502. (PMID: 29527228) Nat Commun. 2014 Sep 19;5:4982. (PMID: 25236782) Adv Nutr. 2015 Nov 13;6(6):803-19. (PMID: 26567202) Am J Respir Crit Care Med. 2015 Feb 15;191(4):427-36. (PMID: 25531246) Cancer Lett. 2016 Sep 28;380(1):114-21. (PMID: 27317873) Cell Rep. 2023 May 30;42(5):112424. (PMID: 37086405) Diabetes. 2000 Aug;49(8):1374-80. (PMID: 10923640) J Biomed Opt. 2013 Aug;18(8):86003. (PMID: 23912760) Integr Biol (Camb). 2015 Oct;7(10):1120-34. (PMID: 25959051) Proc Natl Acad Sci U S A. 2009 Oct 20;106(42):17892-7. (PMID: 19815530) Cancer Res. 2013 Oct 1;73(19):6080-93. (PMID: 23959857) Surg Obes Relat Dis. 2008 Nov-Dec;4(6):691-5. (PMID: 19026373) Nat Commun. 2018 Dec 4;9(1):5150. (PMID: 30514914) Breast Cancer Res Treat. 2006 Aug;98(3):285-94. (PMID: 16541324) Ann N Y Acad Sci. 1990;593:188-96. (PMID: 1695824) J Clin Endocrinol Metab. 2014 Mar;99(3):898-907. (PMID: 24423338) Proc Natl Acad Sci U S A. 2018 May 29;115(22):E5096-E5105. (PMID: 29760084) Int J Obes (Lond). 2011 Jan;35(1):91-8. (PMID: 20531347) J Clin Invest. 2001 Jun;107(12):1529-36. (PMID: 11413160) Front Immunol. 2014 Sep 26;5:470. (PMID: 25309549) Cell Rep. 2017 Sep 26;20(13):3149-3161. (PMID: 28954231) Cell Metab. 2013 Dec 3;18(6):816-30. (PMID: 24315368) J Nutr Biochem. 2022 Jan;99:108837. (PMID: 34419570) Ann Surg. 2019 Jan;269(1):95-101. (PMID: 28938270) J Cell Physiol Suppl. 1987;Suppl 5:1-7. (PMID: 3316252) Lab Invest. 2002 Sep;82(9):1183-92. (PMID: 12218079) Stem Cell Res Ther. 2015 Apr 14;6:72. (PMID: 25884374) Breast Cancer Res. 2015 Aug 19;17:112. (PMID: 26286584) J Clin Endocrinol Metab. 2012 Oct;97(10):E1880-9. (PMID: 22851489) Exp Cell Res. 2005 Mar 10;304(1):81-90. (PMID: 15707576) Int J Cancer. 2008 Nov 15;123(10):2229-38. (PMID: 18777559) Mol Carcinog. 2013 Jun;52(6):446-58. (PMID: 22290600) Nat Commun. 2019 Jan 17;10(1):281. (PMID: 30655530) Biochem Biophys Res Commun. 2008 May 2;369(2):471-7. (PMID: 18291098) J Clin Invest. 2007 Jan;117(1):175-84. (PMID: 17200717) Adv Funct Mater. 2020 Nov 25;30(48):. (PMID: 33692663) Differentiation. 2002 May;70(2-3):84-91. (PMID: 12076335) Diabetes. 2010 Nov;59(11):2817-25. (PMID: 20713683) Front Cell Dev Biol. 2019 Jul 05;7:86. (PMID: 31334229) J Biochem. 2012 Oct;152(4):321-9. (PMID: 22923731) Stem Cells Dev. 2013 Mar 15;22(6):985-97. (PMID: 23137270) J Biol Chem. 2007 Aug 3;282(31):22910-20. (PMID: 17556364) Mol Med. 1994 Nov;1(1):71-81. (PMID: 8790603) Stem Cells. 2014 May;32(5):1347-60. (PMID: 24446236) Endocr Relat Cancer. 2011 Jul 11;18(4):C25-9. (PMID: 21680729) Differentiation. 1998 Aug;63(4):193-200. (PMID: 9745710) Am J Physiol. 1998 Sep;275(3):E507-15. (PMID: 9725819) PLoS One. 2012;7(3):e34082. (PMID: 22479530) Cancers (Basel). 2021 Jul 11;13(14):. (PMID: 34298680) Oncotarget. 2016 Feb 23;7(8):8809-22. (PMID: 26684242) Dis Model Mech. 2015 Jun;8(6):543-51. (PMID: 26035864) JAMA Oncol. 2018 Nov 1;4(11):e181771. (PMID: 29931120) Cancer Cell Int. 2016 Apr 01;16:26. (PMID: 27042159) Breast Cancer Res Treat. 2013 Jan;137(1):307-14. (PMID: 23179600) Eur J Obstet Gynecol Reprod Biol. 2018 Nov;230:217-221. (PMID: 29730021) Am J Pathol. 2019 Oct;189(10):2019-2035. (PMID: 31323189) Diabetes. 2005 Aug;54(8):2277-86. (PMID: 16046292) Eur Respir Rev. 2013 Dec;22(130):552-7. (PMID: 24293471) Biochem Biophys Res Commun. 2013 Aug 2;437(3):397-402. (PMID: 23831470) Oncologist. 2014 Oct;19(10):1076-83. (PMID: 25142841) Cancer Prev Res (Phila). 2022 Sep 1;15(9):581-594. (PMID: 35696725) Stem Cell Res Ther. 2021 Apr 16;12(1):245. (PMID: 33863385) Dev Dyn. 2009 May;238(5):1092-9. (PMID: 19384959) Breast Cancer Res. 2020 Sep 29;22(1):102. (PMID: 32993755) Am J Respir Cell Mol Biol. 2014 Dec;51(6):793-801. (PMID: 24885373) Mol Med. 1997 Jan;3(1):37-48. (PMID: 9132278) Annu Rev Pathol. 2008;3:99-126. (PMID: 18039143) J Clin Invest. 2011 Jun;121(6):2094-101. (PMID: 21633177) J Lipid Res. 2005 Nov;46(11):2347-55. (PMID: 16150820) Nat Commun. 2022 May 26;13(1):2950. (PMID: 35618862) Cell Metab. 2013 Sep 3;18(3):355-67. (PMID: 24011071) Cell Metab. 2016 Apr 12;23(4):591-601. (PMID: 26916363) CA Cancer J Clin. 2017 Sep;67(5):378-397. (PMID: 28763097) Cytotherapy. 2013 Jun;15(6):641-8. (PMID: 23570660) J Clin Oncol. 2016 Dec 10;34(35):4203-4216. (PMID: 27903149) J Exp Clin Cancer Res. 2022 Jan 5;41(1):9. (PMID: 34986886) FASEB J. 2005 Dec;19(14):2029-31. (PMID: 16188961) J Clin Invest. 2003 Dec;112(12):1821-30. (PMID: 14679177) Nat Rev Cancer. 2004 Aug;4(8):579-91. (PMID: 15286738) Protoplasma. 2017 May;254(3):1219-1232. (PMID: 28150048) Cell Rep. 2014 May 22;7(4):1116-29. (PMID: 24794440) Cancer Cell. 2018 Mar 12;33(3):463-479.e10. (PMID: 29455927) Pathobiology. 2018;85(5-6):311-321. (PMID: 30223270) Breast Cancer Res. 2017 Jan 19;19(1):8. (PMID: 28103902) J Clin Endocrinol Metab. 2012 Sep;97(9):E1677-85. (PMID: 22745246) Sci Transl Med. 2015 Aug 19;7(301):301ra130. (PMID: 26290412) Immunometabolism. 2019;1:. (PMID: 31396408) Cancer Res. 2012 Oct 15;72(20):5198-208. (PMID: 23071132) Mol Endocrinol. 2009 Jan;23(1):11-24. (PMID: 18945811) FASEB J. 1997 Jan;11(1):51-9. (PMID: 9034166) Respir Res. 2017 Sep 15;18(1):172. (PMID: 28915889) Nat Rev Immunol. 2011 Jun;11(6):427-35. (PMID: 21597472) Am J Physiol Endocrinol Metab. 2013 May 1;304(9):E964-76. (PMID: 23482446) Metabolism. 2005 Nov;54(11):1546-51. (PMID: 16253647) Br J Surg. 2018 Nov;105(12):1650-1657. (PMID: 30003539) Breast Cancer Res Treat. 2011 Nov;130(2):587-97. (PMID: 21667121) Gastric Cancer. 2015 Apr;18(2):306-13. (PMID: 24792410) FASEB J. 2012 Oct;26(10):4327-36. (PMID: 22772162) J Clin Endocrinol Metab. 2016 Jan;101(1):293-304. (PMID: 26583585) Cell Res. 2009 Feb;19(2):156-72. (PMID: 19153598) J Natl Cancer Inst. 2014 Mar;106(3):djt465. (PMID: 24552677) J Clin Invest. 2010 Oct;120(10):3466-79. (PMID: 20877011) Endocr Connect. 2021 Mar;10(3):325-335. (PMID: 33617465) Breast Cancer Res Treat. 2011 Feb;125(3):687-96. (PMID: 20361254) Am J Physiol Endocrinol Metab. 2014 Feb;306(3):E247-55. (PMID: 24326418) Stem Cells. 2006 May;24(5):1246-53. (PMID: 16410391) Cancer Prev Res (Phila). 2011 Jul;4(7):1021-9. (PMID: 21622727) Endocrinology. 2007 Feb;148(2):868-77. (PMID: 17082259) J Clin Endocrinol Metab. 2017 Jul 1;102(7):2443-2453. (PMID: 28419237) J Cell Physiol. 2007 Sep;212(3):702-9. (PMID: 17477371) J Clin Oncol. 2009 Mar 10;27(8):1160-7. (PMID: 19204204) Cancer Commun (Lond). 2022 May;42(5):401-434. (PMID: 35481621) Kidney Dis (Basel). 2021 Sep 28;8(1):26-43. (PMID: 35224005) Immunometabolism. 2020;2(3):. (PMID: 32774894) Int J Mol Sci. 2021 Oct 27;22(21):. (PMID: 34769066) Cancer Epidemiol Biomarkers Prev. 2009 Apr;18(4):1157-66. (PMID: 19336554) Cancer Res. 2013 Sep 15;73(18):5657-68. (PMID: 23903958) Diabetes. 2007 Jan;56(1):16-23. (PMID: 17192460) N Engl J Med. 2009 Oct 15;361(16):1570-83. (PMID: 19828534) Breast Cancer Res. 2017 Jan 11;19(1):4. (PMID: 28077158) Br J Haematol. 2005 Apr;129(1):118-29. (PMID: 15801964) Physiol Rev. 2021 Jan 1;101(1):147-176. (PMID: 32466724) Obes Surg. 2017 Nov;27(11):3014-3020. (PMID: 28840450) Nat Commun. 2016 Jun 03;7:11703. (PMID: 27256716) Nat Med. 2009 Aug;15(8):940-5. (PMID: 19633655) Cell Metab. 2014 Oct 7;20(4):614-25. (PMID: 25242226) Int J Cancer. 2009 Feb 1;124(3):698-712. (PMID: 18988226) J Immunol. 2003 Jul 1;171(1):380-9. (PMID: 12817021) J Immunol. 1993 May 1;150(9):4188-96. (PMID: 8473757) Int J Cancer. 2003 Aug 10;106(1):96-102. (PMID: 12794763) Blood. 2010 Jul 15;116(2):157-64. (PMID: 20233971) Epidemiol Rev. 2014;36:114-36. (PMID: 24375928) World J Stem Cells. 2020 Jan 26;12(1):1-7. (PMID: 32110271) Wound Repair Regen. 2007 Jan-Feb;15(1):113-21. (PMID: 17244327) Cells. 2020 Dec 25;10(1):. (PMID: 33375695) Mol Cell Biol. 2009 Aug;29(16):4467-83. (PMID: 19546236) Int J Mol Sci. 2016 Dec 29;18(1):. (PMID: 28036074) Cell Metab. 2013 Oct 1;18(4):470-7. (PMID: 23954640) EMBO Rep. 2021 Aug 4;22(8):e52835. (PMID: 34196465) J Clin Invest. 2008 Feb;118(2):710-21. (PMID: 18202748) Breast Cancer Res Treat. 2014 Sep;147(2):237-48. (PMID: 25119728) Obes Rev. 2014 Sep;15(9):749-68. (PMID: 24891269) Cell Mol Bioeng. 2016 Oct 19;10(1):114-123. (PMID: 31719853) J Gastroenterol Hepatol. 2003 Jun;18(6):666-72. (PMID: 12753148) Diabetes. 2010 May;59(5):1171-81. (PMID: 20185806) Breast Cancer Res Treat. 2008 Sep;111(2):329-42. (PMID: 17939036) Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):439-43. (PMID: 17372238) Dev Biol. 2010 Jan 1;337(1):124-33. (PMID: 19850030) Metabolism. 2018 Jan;78:118-127. (PMID: 29051043) Lipids Health Dis. 2011 Nov 03;10:198. (PMID: 22051061) Cancers (Basel). 2023 Jan 12;15(2):. (PMID: 36672434) J Proteome Res. 2010 Apr 5;9(4):1754-62. (PMID: 20184379) FASEB J. 2020 Jun;34(6):8611-8624. (PMID: 32359100) Kidney Int. 2007 Aug;72(3):269-73. (PMID: 17495856) J Exp Med. 2019 Jun 3;216(6):1345-1358. (PMID: 31053611) Adv Exp Med Biol. 2018;1092:91-112. (PMID: 30368750) Breast Cancer Res. 2005;7(5):R833-43. (PMID: 16168130) Breast. 2017 Apr;32:237-244. (PMID: 27318645) BJOG. 2006 Oct;113(10):1160-6. (PMID: 16945118) Cancers (Basel). 2020 Jul 28;12(8):. (PMID: 32731354) Cancer Prev Res (Phila). 2016 May;9(5):339-48. (PMID: 26869351) Mol Cell Biol. 2017 Feb 1;37(4):. (PMID: 27895151) BMC Med Genomics. 2012 Sep 06;5:39. (PMID: 22954256) J Breast Cancer. 2015 Jun;18(2):149-59. (PMID: 26155291) Front Med (Lausanne). 2020 Nov 05;7:583708. (PMID: 33251232) J Clin Invest. 2006 Jun;116(6):1494-505. (PMID: 16691291) BMC Med. 2008 Apr 28;6:11. (PMID: 18442412) J Cell Mol Med. 2021 Sep;25(18):9051-9059. (PMID: 34418300) J Hepatol. 2006 Sep;45(3):429-38. (PMID: 16846660) J Clin Oncol. 2011 Jan 1;29(1):25-31. (PMID: 21115856) J Immunol. 2001 Jun 15;166(12):7556-62. (PMID: 11390511) BMC Genomics. 2013 Sep 16;14:625. (PMID: 24040759) Mol Carcinog. 2021 Feb;60(2):73-100. (PMID: 33428807) Diabetes. 2007 Dec;56(12):2910-8. (PMID: 17848624) Sci Transl Med. 2011 Nov 9;3(108):108ra113. (PMID: 22072638) Front Oncol. 2021 Feb 24;11:620773. (PMID: 33718177) Cell Metab. 2017 Mar 7;25(3):673-685. (PMID: 28215843) Cell Death Dis. 2016 Dec 1;7(12):e2495. (PMID: 27906172) Sci Rep. 2018 Oct 12;8(1):15203. (PMID: 30315279) Nat Mater. 2021 Apr;20(4):548-559. (PMID: 33257795) Front Immunol. 2019 Dec 13;10:2759. (PMID: 31921102) Breast Cancer Res Treat. 2019 Feb;174(1):209-218. (PMID: 30465158) Cancer Res. 2020 Oct 15;80(20):4465-4475. (PMID: 32868380) Physiol Rev. 1997 Oct;77(4):1033-79. (PMID: 9354811) Cancer Biol Ther. 2006 Dec;5(12):1640-6. (PMID: 17106243) Clin Med Insights Oncol. 2014 Sep 11;8:107-11. (PMID: 25249766) Genes Nutr. 2014 May;9(3):391. (PMID: 24718728) Am J Respir Cell Mol Biol. 2006 Aug;35(2):175-81. (PMID: 16543609) Nat Rev Immunol. 2017 Sep;17(9):559-572. (PMID: 28555670) Elife. 2020 Jun 01;9:. (PMID: 32479261) Breast Cancer Res. 2017 Jan 19;19(1):9. (PMID: 28103936) Biomedicines. 2020 May 14;8(5):. (PMID: 32423179) Mol Cell Biol. 2009 Mar;29(6):1575-91. (PMID: 19114551) Am J Physiol Endocrinol Metab. 2010 Dec;299(6):E1016-27. (PMID: 20841504) N Engl J Med. 2003 Apr 24;348(17):1625-38. (PMID: 12711737) Mol Cell Biol. 2013 Mar;33(5):904-17. (PMID: 23249949) Int J Obes (Lond). 2013 Jun;37(6):867-73. (PMID: 23399771) Fibrogenesis Tissue Repair. 2011 Jan 10;4:2. (PMID: 21219601) Am J Physiol Endocrinol Metab. 2013 Dec;305(12):E1427-35. (PMID: 24105412) Cancers (Basel). 2020 Jun 26;12(6):. (PMID: 32604738) Ann Surg. 2020 Dec;272(6):1053-1059. (PMID: 30998538) Oncologist. 2010;15(6):556-65. (PMID: 20507889) Int J Obes (Lond). 2019 Jun;43(6):1281-1294. (PMID: 30301967) Int J Biochem Cell Biol. 2010 May;42(5):662-71. (PMID: 20034590) Pharmaceuticals (Basel). 2017 Aug 09;10(3):. (PMID: 28792472) J Clin Invest. 2003 Dec;112(12):1796-808. (PMID: 14679176) J Clin Invest. 2006 Jan;116(1):115-24. (PMID: 16341265) Endocrinology. 2008 Mar;149(3):1350-7. (PMID: 18048491) J Clin Endocrinol Metab. 2009 Nov;94(11):4619-23. (PMID: 19837929) Clin Cancer Res. 2015 Aug 1;21(15):3561-8. (PMID: 25695692) Breast Cancer Res Treat. 2020 Feb;180(1):55-61. (PMID: 31933142) World J Surg Oncol. 2018 Jan 2;16(1):1. (PMID: 29291744) J Am Soc Nephrol. 2017 Jul;28(7):2053-2067. (PMID: 28209809) Eur J Surg Oncol. 2012 Apr;38(4):307-13. (PMID: 22264965) Cancer Lett. 2018 Oct 1;433:1-9. (PMID: 29935374) Int J Obes (Lond). 2008 Mar;32(3):451-63. (PMID: 17895881) Front Oncol. 2022 Aug 08;12:964934. (PMID: 36003773) Obesity (Silver Spring). 2017 Nov;25 Suppl 2:S52-S57. (PMID: 29086527) Neoplasia. 2018 Nov;20(11):1161-1174. (PMID: 30317122) Proc Natl Acad Sci U S A. 2003 Jun 10;100(12):7265-70. (PMID: 12756299) Sci Rep. 2015 Jul 24;5:11664. (PMID: 26206182) J Leukoc Biol. 2016 Jun;99(6):935-53. (PMID: 26701132) |
| معلومات مُعتمدة: | F31 CA247265 United States CA NCI NIH HHS; R01 CA227542 United States CA NCI NIH HHS; F31CA247265 United States CA NCI NIH HHS; R01CA227542 United States CA NCI NIH HHS |
| فهرسة مساهمة: | Keywords: adipocytes; breast cancer; cancer-associated fibroblasts; extracellular matrix; macrophages; mammary gland; obesity |
| تواريخ الأحداث: | Date Created: 20230610 Latest Revision: 20230613 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC10252103 |
| DOI: | 10.3390/cancers15112929 |
| PMID: | 37296891 |
| قاعدة البيانات: | MEDLINE |
Full Text Finder | تدمد: | 2072-6694 |
|---|---|
| DOI: | 10.3390/cancers15112929 |